NEW YORK, July 9, 2024 /PRNewswire/ -- Today, Kaia Health (Kaia) released the follow-up results of its landmark randomized controlled trial—the Rise-uP study. The study revealed superior long-term outcomes in clinical improvement and cost savings for a digital-first treatment approach to lower back pain..

纽约，2024年7月9日/PRNewswire/--今天，Kaia Health（Kaia）发布了其里程碑式随机对照试验Rise up研究的后续结果。该研究显示，数字首治腰痛的方法在临床改善和成本节约方面具有优异的长期效果。。

Continue Reading

继续阅读

Kaia users report higher pain reduction compared to the control group after 12 months.

。

In a study cohort of over 1,200 randomized participants—the largest of its kind in the space—patients following Kaia's digital-first treatment saw a significant reduction in pain as well as positive improvements across physical function, mental health, and overall reduction in the cost of care compared to standard treatments after 12 months..

在一项由1200多名随机参与者组成的研究队列中，与12个月后的标准治疗相比，接受Kaia数字首次治疗的太空中最大的一类患者的疼痛显着减轻，身体功能，心理健康得到积极改善，护理成本总体降低。。

Key Findings:

主要发现：

Significant Pain Reduction: Participants using the Kaia app experienced a 46% reduction in pain intensity, compared to a 24% reduction in the control group. This builds on the initial three-month findings, which showed a 33% pain reduction in the Kaia group compared to 14% in the control group.Improved Functional Ability: Users of the Kaia app achieved clinically significant improvements in functional ability and physical wellbeing compared to the control group who showed little to no change.Mental Health Benefits: The study found lasting improvements in mental health for Kaia app users, with participants reporting reduced anxiety, depression, and stress levels as well as improved mental well-being.

显着减轻疼痛：使用Kaia应用程序的参与者疼痛强度降低了46%，而对照组降低了24%。这建立在最初的三个月研究结果的基础上，该结果显示Kaia组疼痛减轻33%，而对照组疼痛减轻14%。功能能力提高：与对照组相比，Kaia应用程序的用户在功能能力和身体健康方面取得了临床显着改善，而对照组几乎没有变化。心理健康益处：该研究发现Kaia应用程序用户的心理健康状况持续改善，参与者报告焦虑，抑郁和压力水平降低，心理健康状况改善。

Patients in the control group saw deteriorating mental health trends over the same time period, validating the importance of a holistic approach to managing chronic pain and enhancing overall well-being.Increased Patient Satisfaction: Participants in the Kaia group reported higher levels of satisfaction with their treatment compared to the control group.Cost-Effectiveness: Participants in the Rise-uP group saw an 81% decrease in overall healthcare costs compared to the control group, primarily driven by a reduction in costs associated with inpatient (hospital) treatment, medication costs, and incapacity for work.'We are pleased by the long-term results of the Rise-uP trial, which confirm the impact of Kaia Health's digital therapy on pain management and overall well-being,' said Konstantin Mehl, Founder and CEO, Kaia Health.

对照组患者在同一时间段内心理健康趋势恶化，验证了整体治疗慢性疼痛和提高整体幸福感的重要性。患者满意度提高：与对照组相比，Kaia组的参与者对治疗的满意度更高。成本效益：与对照组相比，Rise uP组的参与者总体医疗费用下降了81%，主要是由于住院（医院）治疗、药物费用和丧失工作能力相关费用的降低。“我们对Rise uP试验的长期结果感到高兴，这证实了Kaia Health的数字治疗对疼痛管理和整体幸福感的影响，”Kaia Health创始人兼首席执行官康斯坦丁·梅尔（KonstantinMehl）说。

'These findings reinforce our commitment to providing innovative, cost-effective, accessible digital health solutions that improve the lives of people suffering from chronic pain.'For more detailed information, please refer to the full report here.About .

“这些发现强化了我们提供创新、经济高效、可访问的数字健康解决方案的承诺，这些解决方案可以改善慢性疼痛患者的生活。”有关更多详细信息，请参阅此处的完整报告。关于。